InvestorsHub Logo
Followers 20
Posts 1264
Boards Moderated 0
Alias Born 04/13/2013

Re: nobrainerstocks post# 89572

Thursday, 02/02/2017 2:21:18 PM

Thursday, February 02, 2017 2:21:18 PM

Post# of 464599
Absolutely. Just for MS. If 2-73 is a successful remyelinating compound, that would be a game changer for treating MS and could create a multi-billion dollar revenue stream for Biogen.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News